British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been ... Joseph Bayer – filed for dismissal without any settlement payment from GSK, which was named as a defendant ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

(Alliance News) - GSK PLC on Wednesday said it reached two confidential settlements regarding the Zantac case in California State Court. The London-based pharmaceutical company said the cases ...

GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court ...

The analyst believes that Zantac litigation has "disproportionately ... while the worst-case scenario for settlements – which Conroy said it up to $30bn – has already been priced into the ...

(Alliance News) - GSK PLC on Wednesday said it reached two confidential settlements regarding the Zantac case in California State Court. The London-based pharmaceutical company said the cases ...

GSK reached a settlement with plaintiff Isaac Dixon, resolving a case related to its discontinued heartburn medicine Zantac allegedly causing prostate cancer, filed in Illinois State court.

(RTTNews) - Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California State Court against heartburn drug Zantac (ranitidine ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...